Additive antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy under angiotensin receptor blockade: A short-term, randomized, and controlled trial

Aims and Objectives: The aims of this study were to study the safety and efficacy of pentoxifylline added on to an angiotensin II receptor blocker (ARB) to reduce the progression of the disease condition in diabetic nephropathy (DN) patients over 1 year. Diabetic Nephropathy; Pentoxifylline; Urine A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	National journal of physiology, pharmacy and pharmacology pharmacy and pharmacology, 2022, Vol.12 (6), p.1-827
Hauptverfasser:	Thottol, Reema, George, Ancy, G, Laxmi
Format:	Artikel
Sprache:	eng
Schlagworte:	Chronic illnesses Creatinine Cytokines Diabetes Diabetic nephropathy Diabetic retinopathy Endocrine system Extracellular matrix Hepatitis Hyperglycemia Hypertension Kidney diseases Metabolism Nephrology Proteins Tumor necrosis factor-TNF Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!